Insights On Partnering

91. Case Study: Ulcerative Colitis
    5/11/2011
    According to the Centers for Disease Control (CDC), data suggest that the number of people worldwide who suffer from ulcerative colitis (UC) — a chronic and serious disease of the colon — varies greatly, from 0.1 person per 100,000 to 16 people per 100,000.
92. Case Study: Flu Vaccine Trial Accelerated Despite Late-In-Season Start
    5/11/2011
    Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.
93. Case Study: Recruitment Expertise Reduces High Screen Failure Rate
    5/11/2011
    The Quintiles team developed a profile of patients who would be more likely to fulfill criteria and distributed it to sites.
94. Case Study: Post-Marketing Commitment Study
    5/11/2011
    Pharmaceutical companies are feeling the pressure of a new level of regulatory scrutiny surrounding post-marketing commitment studies.
95. Case Study: Advanced Prostate Cancer Phase III Study
    5/11/2011
    Two studies sought to evaluate the efficacy of the 15mg 4-month formulation or 22.5mg 6-month formulation in achieving castrate levels of testosterone (=1.735nmol/L) on Day 29 (i.e., 28 days after study drug injection).
96. The Impact Of Globalization On The Statistical Services
    5/11/2011
    Jorgen Seldrup was a discussant in a session on "The Impact of Globalization on the Statistical Services" at the ISBS/EMA/IBS-DR Joint Conference in Berlin on March 1, 2011.
97. Bypassing Barriers - Refractory Partial Epilepsy
    5/11/2011
    Clinical Monitoring, Project Management, Data Management, Statistics, Medical Writing, Central Laboratories, and Safety Pharmacology.
98. White Paper: The Art Of Compliance - Turning Compliance Into A Sustainable Business Advantage
    5/11/2011
    The past few years have presented extraordinary regulatory and quality compliance challenges for pharmaceutical, biotechnology, and medical device companies. They are required to do more with less as a result of consolidation, restructuring, and economic uncertainty.
99. Case Study: Simplifying Data Management In A Complex Study
    5/11/2011
    For a Global trial, our customer worked with multiple players, including affiliates and an external CRO.
100. Biomarkers In Alzheimers Disease
     5/11/2011
     Christine Betard and Dr. Judith Abdalla are Executive Directors, Global Strategic Drug Development, within Quintiles Innovation Unit.